Lung bioavailability of hydrofluoroalkane fluticasone in young children when delivered by an antistatic chamber/mask - 09/08/11
Reprint requests: Leslie Hendeles, PharmD, University of Florida, PO Box 100486, Gainesville, FL 32610-0486.Résumé |
Objective |
To determine whether an antistatic valved holding chamber/mask improves lung bioavailability of hydrofluoroalkane (HFA) fluticasone in young children.
Study design |
Twelve patients, age 1 to 6 years, with well-controlled asthma were treated with an HFA fluticasone metered-dose inhaler (Flovent HFA) twice daily (440 μg/day). The drug was delivered by tidal breathing through conventional (AeroChamber Plus) and antistatic (AeroChamber MAX) valved holding chambers (VHCs) with masks in a randomized, crossover manner, each for 3 to 7 days. When adherence was 100% at home, blood was collected for measurement of steady-state fluticasone plasma concentration (FPC) 1 hour after the last dose was administered in the clinic. FPC indicates systemic exposure directly and airway delivery indirectly. It was measured by liquid chromatography-mass spectrometry. Data were analyzed by regression analysis.
Results |
The mean ± SD FPC was 107 ± 30 pg/mL after conventional VHC and 186 ± 134 pg/mL after the antistatic VHC (P = .03). In 5 patients (40%), the antistatic VHC increased FPC by ≥ 100%, to potentially excessive levels in 4 of them; it had little effect in 7 patients.
Conclusions |
HFA fluticasone was delivered to the airways by both devices even though the patients could not inhale deeply and breath hold. The antistatic VHC variably increased lung bioavailability. To reduce systemic exposure, the dose should be weaned to the minimum required to maintain asthma control.
Le texte complet de cet article est disponible en PDF.Abbreviations : CFC, FDA, FPC, HFA, pMDI, VHC
Plan
| Supported in part by an investigator-initiated grant from GlaxoSmithKline and grants from the National Institutes of Health (NIH) National Center for Research Resources (MO1-RR00082) and the NIH Research Facilities Construction Program (RR17568). |
Vol 149 - N° 6
P. 793-797 - décembre 2006 Retour au numéro
Article précédent
- Comparison of chronic illness among children receiving mechanical ventilation in a cohort of children’s hospitals in 1991 and 2001
- Edward G. Seferian, Kandace A. Lackore, Ahmed S. Rahman, James M. Naessens, Arthur R. Williams
- Leptin levels decline steadily during prolonged fasting in lean children
- Lorraine E. Levitt Katz, Máire Abraham, Line Johansen, Abbas F. Jawad
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?